3
Total investments
2
Early stage
0
Mid stage
0
Late stage
6y
Years active
Portfolio
3 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jun 2021
ELIOS is a microinvasive, implant-free procedure that uses excimer laser light energy to create microscopic openings in the trabecular meshwork to re-establish the natural flow of eye fluid, or aqueous.
Investor
Nov 2020
Veradermics is a late clinical-stage biopharmaceutical company founded by dermatologists with direct clinical experience in the treatment of pattern hair loss, a chronic condition that affects 50 million men and 30 million women in the US alone.
Our team combines dermatology expertise, clinical research leadership, and biotechnology innovation to advance new solutions and help bring clarity, evidence, and reliability to pattern hair loss.
Our mission: to set a new standard in pattern hair loss by developing treatments rooted in real evidence.
Our lead investigational product has the potential to be the first non-hormonal oral therapeutic for hair regrowth in men and women. Pattern hair loss is the largest aesthetics condition worldwide, with no new approved prescription therapies in nearly 30 years.
Learn more at www.veradermics.com
Experience ยท 7 entries
All (7)
Investments (3)
2025
Director, ETFs
Mar 2025
Grayscale enables investors to access the digital economy through a family of future-forward investment products. Founded in 2013, Grayscale has a decade-long track record and deep expertise as an asset management firm focused on crypto investing. Investors, advisors, and allocators turn to Grayscale for single asset, diversified, and thematic exposure.
Disclosure: grayscale.com/terms-of-service
2023
2022
Product Development & Capital Markets
Sep 2022
BondBloxx Investment Management Corporation (BondBloxx) is the first ETF issuer to focus solely on bringing more choice and flexibility to fixed income investors, offering a range of exposures spanning U.S. Treasuries, investment grade, high yield, tax-aware and emerging markets bonds. To learn more about BondBloxxs fixed income-first mission, visit BondBloxxETF.com.
Investors should consider the investment objectives, risks, charges and expenses carefully before investing. This and other important information can be found in the BondBloxx ETFs statutory and summary prospectuses. To obtain a free prospectus, please visit bondbloxxetf.com. Please read the prospectus carefully before investing. The BondBloxx ETFs are distributed by Foreside Fund Services, LLC.
Venture Fellow
Feb 2022
The Venture Cooperative is a free educational program and inclusive community that makes Laconias investments, processes, and learnings accessible for the next generation of early stage investors.
The first of its kind, this structure expands financial access into the asset class and sheds light on the inner workings of a venture firm.
.
Members financially share in our success, participate in our investment processes, share expertise within our community, and collaborate with early stage founders.
Apply for our next cohort here: https://bit.ly/3e0VPjm
2021
Investor
Jun 2021
ELIOS is a microinvasive, implant-free procedure that uses excimer laser light energy to create microscopic openings in the trabecular meshwork to re-establish the natural flow of eye fluid, or aqueous.
Show all 7 entries โ
Investment activity
2020โ2023 ยท 3 investments
Recent (last 2 years)Earlier
